Dr. Tamara Hannon talks about how many of her pediatric type 2 diabetes patients are overweight (nearly 100%) and how she determines whether they are type 1 or type 2 (mainly through testing for antibodies). She also discusses how all children are currently at risk for obesity and that around …

Dr. Tamara Hannon talks about the possibility of using rosiglitazone as therapy for children and teens. (Note that this video interview was done before the FDA re-approved rosiglitazone for limited use in adults.) She notes that the drug is more effective with metformin and that some patients simply cannot achieve …

Dr. Tamara Hannon talks about the possibility of using one of the most common adult anti-diabetic medications, sulfonylureas, in children. However, she points out that the drugs can only help adults achieve metabolic control in the short-term which concerns her because children and teens with type 2 diabetes definitely need …

Dr. Tamara Hannon talks about the difficult subject of type 2 diabetes complications for adolescents and the challenges they face with the prospect of a longer life with type 2. She also discusses some of the research that has come out that seems to show the disease progressing faster in …

Dr. Tamara Hannon talks about how she advises her patients and the parents of her patients on physical activity. She explains that the current standards are that children need at least 60 minutes of physical activity every single day but that this standard is being less and less met. She …

Dr. Tamar Hannon explains how she educates her patients about carb counting but that there is a lot of confusion and some of the misinformation seems to be coming directly and deliberately from the food companies themselves so it’s important to read labels extremely carefully.

Dr. Tamara Hannon explains how her type 2 patients make the transition to adult-care physicians. Because type 2 is far more common in adults, endocrinologists and physicians who treat adults are actually more used to treating the disease than pediatricians who rarely see type 2 patients. 

Dr. Tamara Hannon addresses Steve’s questions on the future of type 2 diabetes in children, noting that unless we can begin to make changes as a society, the rates will just keep increasing as the obesity rates just keep going up.

I was working with my calculator earlier (my abacus is broken) and figured out that each of you who reads this week’s newsletter saves about $2300. Our publisher, Stephen Freed, spent all of his time finding the best and most interesting articles and people to talk to at the 74th …

There was a lot of activity at the ADA this year and considerable attention was focused on the SGLT2 inhibitors. This class of drugs, which includes the currently approved canagliflozin and dapagliflozin and the hopefully-soon-to-be-approved empagliflozin as well as about 20 others, has been getting a lot of attention because …